Piyush Goyal meets pharma stakeholders to discuss growth, regulation amid global tariff concerns
Union Minister of Commerce and Industry, Piyush Goyal, held an interaction with key stakeholders from India’s pharmaceutical ecosystem, focusing on strengthening industry growth and regulatory reforms. In a social media…
Lupin Ramps Up Strategy to Counter U.S. Tariff Threat, Posts 52% Profit Surge
Mumbai, August 7, 2025 — Indian pharmaceutical giant Lupin is drawing up a multi-pronged strategy to navigate the looming threat of U.S. tariffs, while celebrating a robust 52% year-on-year surge…
Ray of hope for HIV patients, as Hyderabad-based pharma giants secure nod for game-changing HIV drug
Hyderabad: In a ray of hope for HIV patients, particularly for the significant burden in the two-Telugu speaking States of Telangana and Andhra Pradesh, several India pharmaceutical companies have secured…
Indian generic drugs linked to deaths in US? Trade group slams study blaming desi pharma
A study linking Indian-made generic drugs to a higher risk of serious side effects in the US has drawn backlash from the industry’s most influential lobby group, as India moves…
US Tariffs on pharma: What are the potential impact on Indian drugmakers
US tariffs on pharmaceutical imports by the US President Donald Trump have sparked concerns within India’s pharma sector, a global leader in affordable generic drug supplies. In an exclusive interaction…











